Annual EBIT
-$85.90 M
+$36.62 M+29.89%
March 31, 2024
Summary
- As of February 20, 2025, PRTG annual earnings before interest & taxes is -$85.90 million, with the most recent change of +$36.62 million (+29.89%) on March 31, 2024.
- During the last 3 years, PRTG annual EBIT has fallen by -$71.18 million (-483.74%).
- PRTG annual EBIT is now -169.40% below its all-time high of $123.77 million, reached on March 31, 2018.
Performance
PRTG EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.61 M
+$1.24 M+43.41%
September 30, 2024
Summary
- As of February 20, 2025, PRTG quarterly earnings before interest & taxes is -$1.61 million, with the most recent change of +$1.24 million (+43.41%) on September 30, 2024.
- Over the past year, PRTG quarterly EBIT has stayed the same.
- PRTG quarterly EBIT is now -101.29% below its all-time high of $124.77 million, reached on March 31, 2018.
Performance
PRTG Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$78.23 M
+$4.33 M+5.25%
September 30, 2024
Summary
- As of February 20, 2025, PRTG TTM earnings before interest & taxes is -$78.23 million, with the most recent change of +$4.33 million (+5.25%) on September 30, 2024.
- Over the past year, PRTG TTM EBIT has stayed the same.
- PRTG TTM EBIT is now -163.01% below its all-time high of $124.15 million, reached on December 31, 2018.
Performance
PRTG TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PRTG EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +29.9% | 0.0% | 0.0% |
3 y3 years | -483.7% | +60.2% | -429.5% |
5 y5 years | -2350.0% | -1.1% | -1302.0% |
PRTG EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -483.7% | +29.9% | at high | +98.5% | -429.5% | +53.8% |
5 y | 5-year | -2350.0% | +29.9% | -202.3% | +98.5% | -1584.5% | +53.8% |
alltime | all time | -169.4% | +29.9% | -101.3% | +98.5% | -163.0% | +53.8% |
Portage Biotech EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.61 M(-43.4%) | -$78.23 M(-5.2%) |
Jun 2024 | - | -$2.85 M(-88.6%) | -$82.56 M(-2.6%) |
Mar 2024 | -$85.90 M(-29.9%) | -$24.91 M(-49.0%) | -$84.72 M(-49.9%) |
Dec 2023 | - | -$48.87 M(+722.0%) | -$169.22 M(+34.7%) |
Sep 2023 | - | -$5.95 M(+18.7%) | -$125.66 M(+1.9%) |
Jun 2023 | - | -$5.01 M(-95.4%) | -$123.34 M(+0.8%) |
Mar 2023 | -$122.51 M(+729.2%) | -$109.41 M(+1963.5%) | -$122.42 M(+617.5%) |
Dec 2022 | - | -$5.30 M(+46.1%) | -$17.06 M(+7.7%) |
Sep 2022 | - | -$3.63 M(-11.2%) | -$15.85 M(+1.6%) |
Jun 2022 | - | -$4.09 M(+1.0%) | -$15.59 M(+5.5%) |
Mar 2022 | -$14.77 M(+0.4%) | -$4.04 M(-1.1%) | -$14.77 M(-29.2%) |
Dec 2021 | - | -$4.09 M(+21.2%) | -$20.86 M(+14.7%) |
Sep 2021 | - | -$3.37 M(+3.2%) | -$18.18 M(+4.2%) |
Jun 2021 | - | -$3.27 M(-67.7%) | -$17.45 M(+18.6%) |
Mar 2021 | -$14.71 M(+147.2%) | -$10.13 M(+617.3%) | -$14.71 M(+163.7%) |
Dec 2020 | - | -$1.41 M(-46.6%) | -$5.58 M(-2.0%) |
Sep 2020 | - | -$2.64 M(+395.7%) | -$5.69 M(+22.6%) |
Jun 2020 | - | -$533.00 K(-46.3%) | -$4.64 M(-22.0%) |
Mar 2020 | -$5.95 M(+69.8%) | -$993.00 K(-34.9%) | -$5.95 M(-24.1%) |
Dec 2019 | - | -$1.52 M(-4.3%) | -$7.84 M(+19.3%) |
Sep 2019 | - | -$1.59 M(-13.5%) | -$6.58 M(+27.1%) |
Jun 2019 | - | -$1.84 M(-36.1%) | -$5.17 M(+47.9%) |
Mar 2019 | -$3.51 M(-102.8%) | -$2.88 M(+1017.4%) | -$3.50 M(-102.8%) |
Dec 2018 | - | -$258.00 K(+33.7%) | $124.15 M(+0.1%) |
Sep 2018 | - | -$193.00 K(+17.7%) | $124.07 M(+0.1%) |
Jun 2018 | - | -$164.00 K(-100.1%) | $123.93 M(+0.1%) |
Mar 2018 | $123.77 M(<-9900.0%) | $124.77 M(<-9900.0%) | $123.77 M(-619.7%) |
Dec 2017 | - | -$343.00 K(+3.0%) | -$23.82 M(-19.4%) |
Sep 2017 | - | -$333.00 K(+2.5%) | -$29.54 M(-734.9%) |
Jun 2017 | - | -$325.00 K(-98.6%) | $4.65 M(-4951.9%) |
Mar 2017 | -$96.00 K(-99.0%) | -$22.81 M(+275.8%) | -$95.90 K(-100.5%) |
Dec 2016 | - | -$6.07 M(-117.9%) | $20.93 M(-5.6%) |
Sep 2016 | - | $33.86 M(-767.4%) | $22.17 M(-267.6%) |
Jun 2016 | - | -$5.07 M(+183.3%) | -$13.23 M(+44.0%) |
Mar 2016 | -$9.19 M(+112.6%) | -$1.79 M(-62.9%) | -$9.19 M(+3.9%) |
Dec 2015 | - | -$4.83 M(+215.3%) | -$8.84 M(+80.6%) |
Sep 2015 | - | -$1.53 M(+48.3%) | -$4.90 M(+13.3%) |
Jun 2015 | - | -$1.03 M(-28.4%) | -$4.32 M(+0.0%) |
Mar 2015 | -$4.32 M(-34.8%) | -$1.44 M(+62.7%) | -$4.32 M(-11.2%) |
Dec 2014 | - | -$887.20 K(-7.4%) | -$4.87 M(+14.0%) |
Sep 2014 | - | -$958.00 K(-7.2%) | -$4.27 M(+16.7%) |
Jun 2014 | - | -$1.03 M(-48.0%) | -$3.66 M(-44.8%) |
Mar 2014 | -$6.62 M(+358.6%) | -$1.99 M(+581.9%) | -$6.62 M(+29.5%) |
Dec 2013 | - | -$291.40 K(-16.1%) | -$5.12 M(+13.5%) |
Sep 2013 | - | -$347.50 K(-91.3%) | -$4.51 M(-29.2%) |
Jun 2013 | - | -$4.00 M(+732.9%) | -$6.37 M(+328.0%) |
Mar 2013 | -$1.44 M | -$479.90 K(-252.0%) | -$1.49 M(-4.6%) |
Dec 2012 | - | $315.80 K(-114.3%) | -$1.56 M(-31.7%) |
Sep 2012 | - | -$2.21 M(-350.1%) | -$2.28 M(+214.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | $881.90 K(-259.8%) | -$726.60 K(-71.1%) |
Mar 2012 | -$2.47 M(-36.3%) | -$551.90 K(+35.2%) | -$2.51 M(-7.4%) |
Dec 2011 | - | -$408.10 K(-37.1%) | -$2.71 M(-22.3%) |
Sep 2011 | - | -$648.50 K(-28.1%) | -$3.49 M(-17.0%) |
Jun 2011 | - | -$901.50 K(+19.7%) | -$4.20 M(+10.2%) |
Mar 2011 | -$3.88 M(+18.5%) | -$753.10 K(-36.5%) | -$3.81 M(-20.8%) |
Dec 2010 | - | -$1.19 M(-13.0%) | -$4.82 M(+13.9%) |
Sep 2010 | - | -$1.36 M(+166.3%) | -$4.23 M(+18.1%) |
Jun 2010 | - | -$511.90 K(-70.9%) | -$3.58 M(+10.3%) |
Mar 2010 | -$3.28 M(+563.4%) | -$1.76 M(+194.4%) | -$3.24 M(+98.4%) |
Dec 2009 | - | -$596.90 K(-16.4%) | -$1.64 M(+29.3%) |
Sep 2009 | - | -$713.60 K(+303.8%) | -$1.26 M(+79.7%) |
Jun 2009 | - | -$176.70 K(+19.1%) | -$703.90 K(+28.8%) |
Mar 2009 | -$494.20 K(-10.8%) | -$148.40 K(-34.4%) | -$546.50 K(+55.4%) |
Dec 2008 | - | -$226.10 K(+48.1%) | -$351.70 K(+18.4%) |
Sep 2008 | - | -$152.70 K(+691.2%) | -$297.00 K(+1.9%) |
Jun 2008 | - | -$19.30 K(-141.6%) | -$291.50 K(-31.7%) |
Mar 2008 | -$553.90 K(+1758.7%) | $46.40 K(-127.1%) | -$426.80 K(+3710.7%) |
Dec 2007 | - | -$171.40 K(+16.4%) | -$11.20 K(-5700.0%) |
Sep 2007 | - | -$147.20 K(-4.8%) | $200.00(-101.0%) |
Jun 2007 | - | -$154.60 K(-133.5%) | -$19.80 K(-16.1%) |
Mar 2007 | -$29.80 K(-95.1%) | $462.00 K(-388.8%) | -$23.60 K(-102.6%) |
Dec 2006 | - | -$160.00 K(-4.3%) | $917.90 K(+18.6%) |
Sep 2006 | - | -$167.20 K(+5.6%) | $774.00 K(+96.5%) |
Jun 2006 | - | -$158.40 K(-111.3%) | $393.80 K(-172.3%) |
Mar 2006 | -$607.00 K(-84.9%) | $1.40 M(-561.8%) | -$544.50 K(-89.9%) |
Dec 2005 | - | -$303.90 K(-44.5%) | -$5.40 M(+4.0%) |
Sep 2005 | - | -$547.40 K(-50.1%) | -$5.19 M(+6.4%) |
Jun 2005 | - | -$1.10 M(-68.2%) | -$4.88 M(+20.4%) |
Mar 2005 | -$4.01 M(+274.8%) | -$3.45 M(+3492.8%) | -$4.05 M(+171.5%) |
Dec 2004 | - | -$96.10 K(-58.9%) | -$1.49 M(+3.3%) |
Sep 2004 | - | -$233.80 K(-12.9%) | -$1.45 M(+11.3%) |
Jun 2004 | - | -$268.50 K(-70.0%) | -$1.30 M(+22.8%) |
Mar 2004 | -$1.07 M(+394.4%) | -$893.80 K(+1724.1%) | -$1.06 M(+431.8%) |
Dec 2003 | - | -$49.00 K(-43.9%) | -$198.80 K(-14.9%) |
Sep 2003 | - | -$87.40 K(+223.7%) | -$233.70 K(+17.3%) |
Jun 2003 | - | -$27.00 K(-23.7%) | -$199.20 K(-8.6%) |
Mar 2003 | -$216.60 K(-67.6%) | -$35.40 K(-57.8%) | -$217.90 K(-49.6%) |
Dec 2002 | - | -$83.90 K(+58.6%) | -$432.50 K(-35.3%) |
Sep 2002 | - | -$52.90 K(+15.8%) | -$668.00 K(-0.1%) |
Jun 2002 | - | -$45.70 K(-81.7%) | -$668.50 K(-0.4%) |
Mar 2002 | -$669.20 K(+83.7%) | -$250.00 K(-21.7%) | -$671.50 K(+72.5%) |
Dec 2001 | - | -$319.40 K(+498.1%) | -$389.20 K(+136.3%) |
Sep 2001 | - | -$53.40 K(+9.7%) | -$164.70 K(+48.0%) |
Jun 2001 | - | -$48.70 K(-250.8%) | -$111.30 K(+77.8%) |
Mar 2001 | -$364.20 K(-62.0%) | $32.30 K(-134.0%) | -$62.60 K(-34.0%) |
Dec 2000 | - | -$94.90 K | -$94.90 K |
Mar 2000 | -$957.30 K(+202.5%) | - | - |
Mar 1999 | -$316.50 K(-18.8%) | - | - |
Mar 1998 | -$389.60 K | - | - |
FAQ
- What is Portage Biotech annual earnings before interest & taxes?
- What is the all time high annual EBIT for Portage Biotech?
- What is Portage Biotech annual EBIT year-on-year change?
- What is Portage Biotech quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Portage Biotech?
- What is Portage Biotech quarterly EBIT year-on-year change?
- What is Portage Biotech TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Portage Biotech?
- What is Portage Biotech TTM EBIT year-on-year change?
What is Portage Biotech annual earnings before interest & taxes?
The current annual EBIT of PRTG is -$85.90 M
What is the all time high annual EBIT for Portage Biotech?
Portage Biotech all-time high annual earnings before interest & taxes is $123.77 M
What is Portage Biotech annual EBIT year-on-year change?
Over the past year, PRTG annual earnings before interest & taxes has changed by +$36.62 M (+29.89%)
What is Portage Biotech quarterly earnings before interest & taxes?
The current quarterly EBIT of PRTG is -$1.61 M
What is the all time high quarterly EBIT for Portage Biotech?
Portage Biotech all-time high quarterly earnings before interest & taxes is $124.77 M
What is Portage Biotech quarterly EBIT year-on-year change?
Over the past year, PRTG quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Portage Biotech TTM earnings before interest & taxes?
The current TTM EBIT of PRTG is -$78.23 M
What is the all time high TTM EBIT for Portage Biotech?
Portage Biotech all-time high TTM earnings before interest & taxes is $124.15 M
What is Portage Biotech TTM EBIT year-on-year change?
Over the past year, PRTG TTM earnings before interest & taxes has changed by $0.00 (0.00%)